This article was originally published in Start Up
By all accounts, 1997 was a bad year for small medical device companies trying to go public. Does the recent IPO of hearing-aid company Symphonix Devices presage a good market in 1998 for other medical device companies with early-stage technologies?
You may also be interested in...
Companies developing antibiotics to get financial and technical support from more than 20 firms contributing to new AMR Action Fund. Initiative is also pushing for reimbursement reform and other policies to support commercial marketing.
Joe Biden’s presidential campaign now has a plan to address supply chains and encourage US-based manufacturing of prescription drugs. That affirms the unlikely national prominence of the issue – and reduces the chances of meaningful legislation this year.
The change would let FDA forcibly pull prescription and over-the-counter drugs off the market just like vaccines, medical devices and other products.